MarkLMosterMD

Neurology • Philadelphia, PA

Neuro-Ophthalmology

Professor of Neurology and Ophthalmology, Wills Eye Institute, Jefferson Medical College

Join to view full profile

Dr. Moster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moster's full profile

Already have an account?

Office
840 Walnut St
Ste 930
Philadelphia, PA 19107
Phone+1 215-928-3130

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Neuro-Ophthalmology, 1983 - 1984
UPMC Medical Education (Pittsburgh)Residency, Neurology, 1980 - 1983
UPMC Medical EducationInternship, Internal Medicine, 1979 - 1980
SUNY Upstate Medical UniversityClass of 1979

Certifications & Licensure

FL State Medical License 2005 - 2026
PA State Medical License 1980 - 2026
NJ State Medical License 1989 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis Start of enrollment: 2013 Nov 01
Completed
Early Phase 1
Electric Stimulation of the Eye to Improve Vision After Trauma Start of enrollment: 2013 Jul 01
Completed
Not Applicable
A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Start of enrollment: 2013 Jul 01
Completed
Phase 4
REALITY LHON Registry Start of enrollment: 2018 Jan 03
Completed
Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy Start of enrollment: 2014 Jul 14
ACTIVE_NOT_RECRUITING
PHASE1
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year Start of enrollment: 2018 Mar 12
Active, not recruiting
Phase 3
Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) Start of enrollment: 2011 Apr 01
Completed
Not Applicable
Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey Start of enrollment: 2013 Aug 01
Completed
Join now to see all

Publications & Presentations

PubMed

1 citations
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy.
Patrick Yu-Wai-Man, Nancy J Newman, Valérie Biousse, Valerio Carelli, Mark L Moster
JAMA Ophthalmology. 2025-02-01
The TsiogkaSpaeth grid for detection of neurological visual field defects: a validation study.
Anastasia Tsiogka, Mark L Moster, Klio I Chatzistefanou, Efthymios Karmiris, Evangelia Samoli
Neurological Sciences. 2024-06-01
1 citations
Instances of ocular findings in transgender patients undergoing hormonal therapy.
Christian Nieves-Ríos, Jose S Pulido, Sarah Thornton, James P Dunn, Rebecca A Procopio
American Journal of Ophthalmology Case Reports. 2023-12-01

Press Mentions

GenSight Biologics Announces Publication of RESTORE Study Data Demonstrating Sustained Efficacy 3 Years After Unilateral Injection of LUMEVOQ®August 31st, 2021
GenSight Biologics Reports Findings from REALITY Study and REVERSE-RESCUE Analysis Highlighting Positive Benefits from LUMEVOQ™ (GS010) Compared to LHON Natural HistoryDecember 11th, 2019
Literature CommentarySeptember 30th, 2019
Join now to see all

Grant Support

Cerebral Cortical Mechanisms For Control Of SaccadesNational Institute Of Neurological Disorders And Stroke1990–1994

Professional Memberships

American Academy of Ophthalmology - AAO
Member